We are enclosing herewith the Press Release on successful completion of onboarding process of Ayuveer products on Myntra for purchase.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care Ltd announced that its Ayurvedic brand Ayuveer has completed onboarding on Myntra and its products are now available for purchase on the platform and its app. With this addition, the company now has presence across all major Indian e-commerce platforms including Amazon, Flipkart, Nykaa, Glowroad, Jiomart, and Myntra. The company expects FY2025-26 total revenues of ₹35-40 crores with a profit after tax (PAT) margin of 10%, and is targeting ₹100 crores in revenue within 24-36 months. The company also highlighted that the recent closure of its USFDA inspection has cleared it to export OTC drug products to the USA, with export dispatches already resuming after a six-month production pause.
Positive for retail investors: broader e-commerce distribution should support revenue growth, and the cleared USFDA inspection opens up the US export market, which the company expects to drive recovery in coming quarters. The forward guidance (₹35-40 crores in FY26, ₹100 crores within 24-36 months) signals management's confidence, though these remain projections and depend on execution and demand.